Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.89258325
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

233.65 -1.74 (-0.74%)

New 52W High in past week

406.9K

XNAS Volume

XNAS 26 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

5.3 / 100

Technically Bullish

70.4 / 100

271

1Yr Price target upside is 16%

15 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..